UK To Speed New COVID-19 Drug Candidates Into Trials
Collaborative Project Hailed As ‘Transformative’
Executive Summary
The first of six new compounds are expected to begin Phase II testing soon as part of the UK’s ACCORD initiative, a randomized platform trial bringing together government, industry and research organisations to find potential treatments for COVID-19.